Publication | Closed Access

Infliximab monotherapy in Japanese patients with moderate-to-severe plaque psoriasis and psoriatic arthritis. A randomized, double-blind, placebo-controlled multicenter trial

InflammationRheumatologyAutoimmune DiseaseInfliximab MonotherapyMedicineRheumatic DiseasesSystemic TreatmentClinical TrialsClinical DermatologyModerate-to-severe Plaque PsoriasisInflammatory Rheumatic DiseasePharmacotherapyDermatologyPsoriatic ArthritisInflammatory Arthritis